IMMUNE-ONC THERAPEUTICS Trademark

Trademark Overview


On Tuesday, September 6, 2016, a trademark application was filed for IMMUNE-ONC THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IMMUNE-ONC THERAPEUTICS trademark a serial number of 87162559. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, August 14, 2023. This trademark is owned by Immune-Onc Therapeutics, Inc.. The IMMUNE-ONC THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Basic and clinical research in the field of respiratory science and medicine; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products
immune-onc therapeutics

General Information


Serial Number87162559
Word MarkIMMUNE-ONC THERAPEUTICS
Filing DateTuesday, September 6, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, August 14, 2023
Registration Number5148379
Registration DateTuesday, February 21, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Basic and clinical research in the field of respiratory science and medicine; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 10, 2016
Primary Code042
First Use Anywhere DateFriday, July 29, 2016
First Use In Commerce DateFriday, July 29, 2016

Trademark Owner History


Party NameImmune-Onc Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303

Party NameImmune-Onc Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303

Trademark Events


Event DateEvent Description
Monday, August 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, August 14, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, August 11, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, July 31, 2023POST REGISTRATION ACTION MAILED - SEC. 8
Monday, July 31, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 20, 2023TEAS SECTION 8 RECEIVED
Monday, February 21, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 21, 2017REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, January 17, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 5, 2017ASSIGNED TO LIE
Wednesday, December 21, 2016APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, December 20, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, December 20, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 20, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, December 20, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, December 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 13, 2016ASSIGNED TO EXAMINER
Saturday, September 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 9, 2016NEW APPLICATION ENTERED